| Product Name | NebuSelect™ Recombinant Human ALCAM/CD166, hFc-tag |
|---|---|
| Catalog Number | NBL-243121 |
| Alias/Synonyms | ALCAM/CD166; CD166; ALCAM; MEMD; CD6L; KG-CAM |
| Appearance | see COA |
| Molecule Weight | |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | Q13740-1 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-243121-100ug | 100ug | Inquire | Inquire | |
| NBL-243121-1mg | 1mg | Inquire | Inquire | |
| NBL-243121-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human ALCAM/CD166, hFc-tag
Catalog#:
NBL-243121
Description:
NebuSelect™ Recombinant Human ALCAM/CD166, hFc-tag(Cat#NBL-243121) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Trp28-Ala526.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 82.7 kDa. Due to glycosylation, the protein migrates to 90-115 kDa based on Bis-Tris PAGE result.
Target Name:
ALCAM/CD166; CD166; ALCAM; MEMD; CD6L; KG-CAM
Target Information:
Brain metastasis (BM) in non-small-cell lung cancer (NSCLC) has a very poor prognosis. Recent studies have demonstrated the importance of cell adhesion molecules in tumor metastasis.Elevated levels of ALCAM expression promote BM formation in NSCLC through increased tumor cell dissemination and interaction with the brain endothelial cells. Therefore, ALCAM could be targeted to reduce the occurrence of BM.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.